JS
Jonathan Schechter
Director

Jonathan Schechter insider trades: PharmaCyte Biotech (PMCB) stock buys and sales

Director, PharmaCyte Biotech Last trade Jan 7, 2026 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$67K
Bought, last 12 months
2 buys
8
Open-market trades
since 2020
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 7, 2026PMCB↑ Buy$48K
Nov 14, 2025OBLG↑ Buy$19K
Sep 17, 2025OBLG↑ Buy$13K
Sep 16, 2025OBLG↑ Buy$27K
Dec 16, 2022SNPX↓ Sell10b5-1$24K
Oct 30, 2020NTRP↑ Buy$24K
Oct 22, 2020NTRP↑ Buy$28K
Oct 21, 2020NTRP↑ Buy$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PMCB insiders

Open-market trades in the last 12 months

About Jonathan Schechter's insider trades

Jonathan Schechter is a director at PharmaCyte Biotech (PMCB). Since Oct 21, 2020, Jonathan has reported 7 open-market purchases worth $188K and 1 sale worth $24K on SEC Form 4. In the last 12 months: 2 buys ($67K).

1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (17 filings), shares withheld for taxes (2 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMCB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.